S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NYSE:VYGG

Vy Global Growth (VYGG) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free VYGG Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$10.04
▼
$10.06
50-Day Range
$9.99
▼
$10.05
52-Week Range
$9.77
▼
$10.06
Volume
481,448 shs
Average Volume
245,568 shs
Market Capitalization
$577.88 million
P/E Ratio
20.94
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
VYGG stock logo

About Vy Global Growth Stock (NYSE:VYGG)

Vy Global Growth does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the financial, technology, and business services sectors. The company was incorporated in 2020 and is based in Grand Cayman, the Cayman Islands.

VYGG Stock News Headlines

December 16, 2023 | bbc.com
Global growth forecast cut by IMF amid trade tensions
December 1, 2023 | reuters.com
Global economy to slow down but likely avoid recession in 2024
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
August 11, 2023 | investing.com
Vy® Baron Growth Portfolio Class I (IBGIX)
April 8, 2023 | detroitnews.com
IMF head expects less than 3% global economic growth in 2023
April 8, 2023 | bloomberg.com
IMF Warns Five-Year Global Growth Outlook Is Weakest Since 1990
March 17, 2023 | usnews.com
Global Economy
March 8, 2023 | finance.yahoo.com
BlueVoyant Enters 2023 with Momentus Growth and More Than 900 Global Clients
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
February 22, 2023 | finance.yahoo.com
Global Plastic Recycling and Additive Technology Growth Opportunities
February 21, 2023 | finance.yahoo.com
Global Privileged Access Management Solutions Growth Opportunities
February 19, 2023 | morningstar.com
VY® Morgan Stanley Global Franchise R6
February 18, 2023 | morningstar.com
VY® Baron Growth S2
February 17, 2023 | morningstar.com
VY® Morgan Stanley Global Franchise S
February 15, 2023 | morningstar.com
VY® Baron Growth I
February 13, 2023 | finance.yahoo.com
Global Advanced Wound Care Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts
February 10, 2023 | morningstar.com
VY® Baron Growth S
February 8, 2023 | morningstar.com
VY® Morgan Stanley Global Franchise A
January 22, 2023 | cnbc.com
Global economic outlook may be less bad — but we're still not in a good place, IMF chief says
January 13, 2023 | theguardian.com
Global economy risks second recession within three years, warns World Bank
January 12, 2023 | cnbc.com
Why the World bank slashed its global growth outlook
January 12, 2023 | investopedia.com
World Bank Cuts Global Growth Estimates
January 12, 2023 | wsj.com
World Bank Cuts 2023 Global Growth Projection as Inflation Persists
January 11, 2023 | finance.yahoo.com
Economists Fret Over Perils Ahead for Global Growth
January 10, 2023 | finance.yahoo.com
Rebrandly Positions for Growth, Expands Global Executive Team
January 5, 2023 | finance.yahoo.com
Massive Bio Reaffirms Global Growth Strategy with Key C-Suite Hires and Executive Director Appointments
January 5, 2023 | finance.yahoo.com
Kami Vision Announces More Than 800% Growth Since 2018 Marked by Global Expansion, Executive Hires, and Technology Innovation
See More Headlines
Receive VYGG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vy Global Growth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Unclassified
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NYSE:VYGG
CUSIP
N/A
CIK
1822877
Web
vygg.com
Phone
9714-270-1400
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$0.48
Trailing P/E Ratio
20.94
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$18.43 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-63.44%
Return on Assets
4.18%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.16
Quick Ratio
1.16

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.17 per share
Price / Cash Flow
60.35
Book Value
($0.86) per share
Price / Book
-11.69

Miscellaneous

Outstanding Shares
57,500,000
Free Float
N/A
Market Cap
$577.88 million
Optionable
Not Optionable
Beta
-0.10
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:VYGG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media